ASCENT: Dara-KRd in SMM
ASCENT: Phase II Study of Fixed-Duration Therapy With Daratumumab/Carfilzomib/Lenalidomide/Dexamethasone for High-Risk Smoldering MM

Released: December 13, 2022

Expiration: December 12, 2023

Activity

Progress
1
Course Completed